See All Slides - tctmd.com

Slides

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Rod H. Stables

September 14, 2014

Presentation TCT 2014

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Marco Valgimigli

September 14, 2014

Presentation TCT 2014

Physiology Changing Clinical Decision Making: Systematic Use of FFR From the French National Registry Study

Presenter: Javier Escaned, Nico H.J. Pijls, Morton J. Kern, Eric Van Belle

September 14, 2014

Presentation TCT 2014

Yes: The Data from Numerous Randomized Trials and Large Registries are Clear as a Bell!

Presenter: Fausto Feres

September 14, 2014

Presentation TCT 2014

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Susheel Kodali

September 14, 2014

Presentation TCT 2014

The BEST and BASIL 2 Studies: Designs and Goals

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Kenneth Rosenfield

September 14, 2014

Presentation TCT 2014

Management of Arch Obstruction (Native and Recurrent) in Adults with Congenital Heart Disease

Presenter: Ziyad M. Hijazi, John F. Rhodes, Carlos Pedra, Matthew J. Gillespie

September 14, 2014

Presentation TCT 2014

Early Technology Value Assessment: Market Opportunity Versus Development Risk

Presenter: Chaim S. Lotan, Paul G. Yock, Louis A. Cannon, Jay Watkins

September 14, 2014

Presentation TCT 2014

Understanding the Hemodynamics of Heart Failure

Presenter: Russell A. Brandwein, Michael Guiry, Kenneth A. Gorski

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Gregg W. Stone

September 14, 2014

Advertisement

Slides

The Data Strongly Support Heparin!

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Physiology Changing Clinical Decision Making: Systematic Use of FFR From the French National Registry Study

Yes: The Data from Numerous Randomized Trials and Large Registries are Clear as a Bell!

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

The BEST and BASIL 2 Studies: Designs and Goals

Management of Arch Obstruction (Native and Recurrent) in Adults with Congenital Heart Disease

Early Technology Value Assessment: Market Opportunity Versus Development Risk

Understanding the Hemodynamics of Heart Failure

The Data Strongly Support Bivalirudin!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content